HELM INTELLIGENCEJNJ
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Investors should consider the company's strong growth metrics alongside market conditions when evaluating their positions.
Johnson & Johnson has a market capitalization of $645.20B and is currently trading at $265.58, reflecting a decrease of 0.29% from a previous close of $266.35. The stock has a P/E ratio of 24.08 and a revenue growth of 6.05% year-over-year. The company's EPS growth is notable at 90.50%, with a return on equity of 32.87%. The stock's 52-week range is between $173.47 and $281.01.
Some investors cite Johnson & Johnson's robust EPS growth of 90.50% as a sign of strong operational performance. Additionally, the company's return on equity at 32.87% indicates effective management of shareholder equity.
Conversely, some analysts point to the recent price dip of 0.29% as a concern, suggesting potential volatility ahead. Furthermore, the stock's P/E ratio of 24.08 may indicate that it is relatively high compared to industry peers, raising questions about valuation.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly. Free to start.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
Johnson & Johnson has a market capitalization of $645.20B and is currently trading at $265.58, reflecting a decrease of 0.29% from a previous close of $266.35. The stock has a P/E ratio of 24.08 and a revenue growth of 6.05% year-over-year. The company's EPS growth is notable at 90.50%, with a return on equity of 32.87%. The stock's 52-week range is between $173.47 and $281.01.
Conversely, some analysts point to the recent price dip of 0.29% as a concern, suggesting potential volatility ahead. Furthermore, the stock's P/E ratio of 24.08 may indicate that it is relatively high compared to industry peers, raising questions about valuation.
Some investors cite Johnson & Johnson's robust EPS growth of 90.50% as a sign of strong operational performance. Additionally, the company's return on equity at 32.87% indicates effective management of shareholder equity.
Some investors cite Johnson & Johnson's robust EPS growth of 90.50% as a sign of strong operational performance. Additionally, the company's return on equity at 32.87% indicates effective management of shareholder equity. Conversely, some analysts point to the recent price dip of 0.29% as a concern, suggesting potential volatility ahead. Furthermore, the stock's P/E ratio of 24.08 may indicate that it is relatively high compared to industry peers, raising questions about valuation.
Johnson & Johnson has a market capitalization of $645.20B and is currently trading at $265.58, reflecting a decrease of 0.29% from a previous close of $266.35. The stock has a P/E ratio of 24.08 and a revenue growth of 6.05% year-over-year. The company's EPS growth is notable at 90.50%, with a return on equity of 32.87%. The stock's 52-week range is between $173.47 and $281.01.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for JNJ at helmterminal.dev/analyze/JNJ, updated continuously during US market hours. No signup required.